RCM
ALVOW icon

Radcliffe Capital Management’s Alvotech Warrant ALVOW Stock Holding History

Radcliffe Capital Management’s Portfolio ALVOW Stock Details ALVOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-73,073
Closed -$494K – 882
2022
Q3 		$494K Sell
73,073
-4,597
-6% -$3.33K 0.01% 1078
2022
Q2 		$638K Buy
+77,670
New +$70.3K 0.01% 1082

Other funds holding ALVOW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.14% 1-Year Est. Return

Radcliffe Capital Management's ALVOW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Alvotech Warrant (ALVOW) in Q4 2022, closing a stake of 73,073 shares — an estimated $494K sold.

Radcliffe Capital Management first reported a position in ALVOW in Q2 2022 and held it in 2 quarters. The position peaked at $638K in Q2 2022. 22 funds tracked by Wall St. Rank hold ALVOW as of Q4 2022.

  • Radcliffe Capital Management reported no remaining Alvotech Warrant position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 73,073 Alvotech Warrant shares in Q4 2022, an estimated $494K.
  • Radcliffe Capital Management first reported a position in Alvotech Warrant in Q2 2022 and held it in 2 quarters.
  • Radcliffe Capital Management's Alvotech Warrant position peaked at $638K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Alvotech Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.